OLX10212

· Olix Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OLX10212, covering 2025-12-11 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration [Phase 1]